Quest Diagnostics (DGX) to Post Q2 Earnings: What's in Store?
Quest Diagnostics (DGX) second-quarter results are likely to have reflected the solid base business performance and benefits from acquisitions.
Stay updated with breaking news from Haystack Oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quest Diagnostics (DGX) second-quarter results are likely to have reflected the solid base business performance and benefits from acquisitions.
Recently acquired Haystack Oncology will be moving into a 20,000-square-foot lab at the City Garage Science & Technology Center in Baltimore later this summer.
Quest Diagnostics Inc. (DGX), the nation's leading provider of diagnostic information services, on Wednesday announced that it has completed its acquisition of Haystack Oncology.
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
Operator: Hello, and thank you all for standing by. Welcome to the Quest Diagnostics First Quarter 2023 Conference Call. At the request of the company, this call is being recorded.